Galderma deprioritizes study for IL-31 drug; UCB stops work in rare encephalitis

Plus, news about GlycoMimetics and Indivior:

Galderma stops plans to develop nemolizumab in Phase 2: The Swiss dermatology company said it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Bristol Myers joins the legal fight over incoming Medicare drug price negotiations

Bristol Myers Squibb late last week joined Merck and the US Chamber of Commerce in challenging the Biden administration’s signature drug pricing reform — allowing,

June 21, 2023

Doctors Share Their Favorite Pet Theories

A popular thread on medical Reddit, also known as r/medicine or Meddit, asked users for their “favorite personal theory in medicine that you will never

October 23, 2024

Exclusive: mRNA CDMO Vernal Biosciences secures $20M to continue its buildout

Vermont may be known for maple syrup and Ben & Jerry’s ice cream, but one manufacturer wants the Green Mountain State to become a producer

June 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.